Health challenges and importance of using photobiomodulation therapy in patients with epidermolysis bullosa: a cross-sectional study
Lasers in Medical Science · 2025
DOI: 10.1007/s10103-025-04533-5 ↗Kurz gefasst
Querschnittstudie in der Zeitschrift Lasers in Medical Science, 2025. Verfasst von Mariana Silveira Souza und 6 weiteren Autor:innen. Beteiligte Einrichtung: Universidade Federal de Minas Gerais, Department of Oral Surgery and Pathology, Belo Horizonte (Minas Gerais), Brazil. marianasilveirasouza18@gmail.c…. Hauptthemen laut MEDLINE: Low-Level Light Therapy, Epidermolysis Bullosa, Mouth Diseases. Die Arbeit nennt 24 Literaturangaben.
Abstract (Originalsprache)
Epidermolysis bullosa (EB) is a rare genetic disorder affecting connective tissue that causes painful ulcerations and oral disorders. In our study, we aimed to characterize the general and oral health of patients with EB, develop a profile of such patients, and establish prevention and treatment strategies to improve their oral health. In a cross-sectional study conducted participants underwent anamnesis, an oral clinical evaluation, and an oral health orientation. Fisher's test was used to assess associations between clinical variables and oral diseases observed. Twelve patients with EB were examined; 58% were female, and their mean age was 22 years. Anamnesis revealed that 67% of patients were taking medication, 92% were under medical care, 50% had prior hospitalizations, 58% had anemia, and 42% had undergone surgery. Psychological assessments showed that 58% of patients had experienced anxiety, 58% reported good self-esteem, and 31% received psychological counseling. Intraoral exams identified oral mucosal lesions in 58% of patients and carious lesions in 42%. Pain was significantly associated with mucosal lesions (p =.024), and photobiomodulation therapy using a low-level laser was performed to treat oral mucosal lesions. All patients presented better after completing the therapy. The diverse health needs of patients with EB emphasize the importance of individualized care and interventions, including photobiomodulation therapy, to alleviate pain and promote healing. CLINICAL TRIAL NUMBER: not applicable.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Universidade Federal de Minas Gerais, Department of Oral Surgery and Pathology, Belo Horizonte (Minas Gerais), Brazil. marianasilveirasouza18@gmail.com.
- Pontifícia Universidade Católica de Minas Gerais, Department of Dentistry, Belo Horizonte (Minas Gerais), Brazil.
- Pontifícia Universidade Católica de Minas Gerais, Department of Medicine, Belo Horizonte (Minas Gerais), Brazil.
- Ciências Médicas de Minas Gerais, Eye Institute, Belo Horizonte (Minas Gerais, Brazil.
- Pontifícia Universidade Católica de Minas Gerais, Department of Dentistry, Belo Horizonte (Minas Gerais), Brazil. sorayagrossmann@gmail.com.
Zitieren
APA
Silveira Souza, M., Cascão Lopes, L., Grossmann de Almeida, L., Cintra Dantas, M. T., Dutra Gontijo Moura, M., Borges de Almeida, R., & de Mattos Camargo Grossmann, S. (2025). Health challenges and importance of using photobiomodulation therapy in patients with epidermolysis bullosa: a cross-sectional study. Lasers in Medical Science. https://doi.org/10.1007/s10103-025-04533-5
Vancouver
Silveira Souza M, Cascão Lopes L, Grossmann de Almeida L, Cintra Dantas MT, Dutra Gontijo Moura M, Borges de Almeida R, et al. Health challenges and importance of using photobiomodulation therapy in patients with epidermolysis bullosa: a cross-sectional study. Lasers in Medical Science. 2025. doi:10.1007/s10103-025-04533-5
BibTeX
@article{SilveiraSouza2025,
author = {Silveira Souza, Mariana and Cascão Lopes, Laura and Grossmann de Almeida, Luiza and Cintra Dantas, Maria Thaynná and Dutra Gontijo Moura, Mariela and Borges de Almeida, Rinaldo and de Mattos Camargo Grossmann, Soraya},
title = {Health challenges and importance of using photobiomodulation therapy in patients with epidermolysis bullosa: a cross-sectional study},
journal = {Lasers in Medical Science},
year = {2025},
doi = {10.1007/s10103-025-04533-5}
}
EUVIMED